Metabolic capacity and interindividual variation in toxicokinetics of styrene in volunteers.
The aim of the present study was to assess the interindividual variation in styrene toxicokinetics and to correlate this variation with the individual metabolic capacity for cytochrome P450 (CYP), CYP2E1, CYP1A2 and CYP2D6. Twenty male volunteers were exposed on separate occasions to 104+/-3 and 360+/-20 mg/m3 of styrene for 1 h while performing 50 W physical exercise on a bicycle ergometer. Styrene concentrations in blood and mandelic (MA) and phenylglyoxylic acid (PGA) in urine were measured. The metabolic capacity was assessed by phenotyping with chlorzoxazone (CYP2E1), caffeine (CYP1A2), dextromethorphan (CYP2D6) and antipyrine (CYP450). In addition, for the main styrene-metabolising enzyme, CYP2E1, genotyping for the genetic polymorphisms of the gene was performed. The average pulmonary retention of styrene was 62 +/- 7% at both exposure concentrations, and the 24-h excretion of MA and PGA accounted for 58% of the dose at both concentrations. The interindividual variation in styrene kinetics ranged from 19% for the terminal half-life (t(1/2,beta)) of styrene to 41% for the cumulative excretion of MA and PGA. However, no correlation between the apparent blood clearance of styrene (CLapp), t(1/2,beta) of styrene or excretion of MA and PGA on one hand, and the individual metabolic capacity on the other hand was found. Although other explanations cannot be excluded, this lack of correlation might be due to the high apparent blood clearance (1.4 l/min) of styrene, indicating that styrene metabolism is liver-blood-flow-dependent.
Wenker
M A
MA
Coronel Institute, Academic Medical Center, University of Amsterdam, The Netherlands.
Kezić
S
S
Monster
A C
AC
de Wolff
F A
FA
D000293:Adolescent; D000328:Adult; D003577:Cytochrome P-450 Enzyme System / Q000187:drug effects / Q000378:metabolism*; D015444:Exercise; D006038:Glyoxylates / Q000652:urine; D006801:Humans; D007700:Kinetics; D008099:Liver / Q000201:enzymology; D008168:Lung / Q000737:chemistry; D008297:Male; D008333:Mandelic Acids; D020058:Styrene / Q000009:adverse effects* / Q000378:metabolism / Q000493:pharmacokinetics*; D014018:Tissue Distribution
D006038:Glyoxylates; D008333:Mandelic Acids; C012482:phenylglyoxylic acid; D020058:Styrene; D003577:Cytochrome P-450 Enzyme System